Group One Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,697
Closed -$29.7K 7193
2020
Q3
$41K Buy
+3,697
New +$33.8K ﹤0.01% 4772
2020
Q2
Sell
-66,327
Closed -$254K 6350
2020
Q1
$122K Buy
66,327
+61,125
+1,175% +$176K ﹤0.01% 3141
2019
Q4
$18K Sell
5,202
-35,976
-87% -$85.8K ﹤0.01% 4402
2019
Q3
$88K Sell
41,178
-36,144
-47% -$84.2K ﹤0.01% 3647
2019
Q2
$206K Buy
+77,322
New +$278K ﹤0.01% 2834
2019
Q1
Sell
-29,818
Closed -$78.2K 5539
2018
Q4
$72K Sell
29,818
-59,042
-66% -$193K ﹤0.01% 3364
2018
Q3
$391K Buy
88,860
+39,507
+80% +$219K ﹤0.01% 2490
2018
Q2
$355K Buy
+49,353
New +$336K ﹤0.01% 2593
2017
Q3
Sell
-11,001
Closed -$20.2K 5298
2017
Q2
$22K Buy
11,001
+2,356
+27% +$4.6K ﹤0.01% 3920
2017
Q1
$34K Hold
8,645
﹤0.01% 3632
2016
Q4
$42K Buy
+8,645
New +$51.9K ﹤0.01% 3356
2016
Q2
Sell
-7,135
Closed -$45.6K 5035
2016
Q1
$38K Buy
+7,135
New +$41.5K ﹤0.01% 3420
2015
Q4
Sell
-1,255
Closed -$10.6K 5212
2015
Q3
$11K Buy
1,255
+438
+54% +$6.98K ﹤0.01% 4278
2015
Q2
$14K Sell
817
-9,883
-92% -$127K ﹤0.01% 4194
2015
Q1
$124K Buy
+10,700
New +$124K ﹤0.01% 2740

Other funds holding SRNE

Group One Trading's SRNE Position: Q4 2020 in Review

Group One Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2020, closing a stake of 3,697 shares — an estimated $29.7K sold.

Group One Trading first reported a position in SRNE in Q1 2015 and held it in 15 quarters. The position peaked at $391K in Q3 2018. 219 funds tracked by Wall St. Rank hold SRNE as of Q4 2020.

  • Group One Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Group One Trading sold 3,697 Sorrento Therapeutics, Inc. shares in Q4 2020, an estimated $29.7K.
  • Group One Trading first reported a position in Sorrento Therapeutics, Inc. in Q1 2015 and held it in 15 quarters.
  • Group One Trading's Sorrento Therapeutics, Inc. position peaked at $391K in Q3 2018.
  • 219 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2020.

Based on Group One Trading's 13F filing for Q4 2020, filed 10 Feb 2021.